All posts by SWickramatilake

Public View

D.C. Update – March 1, 2017

Image

 

News from the States

Capitol Hill Happenings

Around the Agencies

In the News

Upcoming Events

Stakeholder Spotlight

 

News from the States

Virginia Gov. McAuliffe signs bills to battle opioid crisis

Last week Governor Terry McAuliffe of Virginia signed several bills that aim to address opioid addiction and overdose. Provisions in the bills will: allow community organizations to possess and dispense naloxone to those that they train to use it; allow local health departments to administer harm reduction programs in parts of the State with very high rates of HIV and Hepatitis C; initiate a family assessment and plan of care for mother and baby if an infant was exposed to substances in utero; and mandate that all opioid prescriptions will be transmitted to pharmacies electronically.

Read a press release on the opioid bills here.

Ohio Substance Abuse Monitoring Network newsletter highlights misuse of anticonvulsant medication gabapentin

On Monday the Ohio Substance Abuse Monitoring (OSAM) Network released its newest newsletter, OSAM-o-Gram. The newsletter highlights the use of gabapentin—an anticonvulsant medication—for the treatment of chronic nerve pain in adults. Gabapentin is a non-narcotic medication thought to have a low abuse profile. However, the newsletter notes that among OSAM focus group participants, the medication is increasingly being used illicitly. Misuse of gabapentin is mostly among individuals with a history of opioid abuse.

Read the full newsletter here.

Capitol Hill Happenings

Leaders of House Energy & Commerce Committee send letter to ONDCP Acting Director Chester on fentanyl  

Last week, bipartisan leaders of the House of Representatives Energy and Commerce Committee sent a letter to Kemp Chester, Acting Director of the Office of National Drug Control Policy (ONDCP) focused on fentanyl. Specifically, the letter requested ONDCP’s assistance in questioning federal agencies about their plans to address the synthetic opioid fentanyl. The letter includes fifteen questions related to fentanyl trafficking, overdose deaths, and enforcement efforts. The letter was sent by full committee Chairman Greg Walden (R-OR) and Ranking Member Frank Pallone (D-NJ), as well as Oversight and Investigations Subcommittee Chairman Tim Murphy (R-PA) and Ranking Member Diana DeGette (D-CO). A coordinated response was requested by the Committee from ONDCP by March 2nd.

Read the full letter here.

Around the Agencies

Director of NIDA, Dr. Nora Volkow, blogs about recent National Academy of Sciences report on cannabis and cannabinoids

Last month the National Academy of Sciences, Engineering, and Medicine (NASEM) released a report on The Health Effects of Cannabis and Cannabinoids. The report provides a comprehensive review of scientific evidence related to the health effects and potential medical uses of cannabis, and outlines gaps in current knowledge. Dr. Nora Volkow, Director of the National Institute on Drug Abuse (NIDA), wrote about the new report in her latest blog post. In her blog, Dr. Volkow reviews the major findings of the report and offers reactions to some of the conclusions of the report, noting the complexities of cannabis, cannabinoids, and their health effects, as well as the need for further research.

Read Dr. Volkow’s full blog post here.

Read the National Academy of Sciences report here.

In the News

WHO releases new guidelines on testing for chronic hepatitis B and C

The World Health Organization has released new guidelines on testing for chronic hepatitis B (HBV) and C (HCV).  The guidelines outline the public health approach to strengthening and expanding current testing practices for HBV and HCV, and are meant to be used across age groups and populations. The document is organized into three sections: 1) Introduction: epidemiology, natural history, and in vitro diagnostic assays for HBV and HCV infection; 2) Recommendations: Summary of recommendations, and evidence and rationale for those recommendations; and 3) Implementation: guidance to support implementation of these recommendations at the country level, which includes a framework for country decision-making and planning. These are the first WHO guidelines on testing for chronic HBV and HCV infection, and they complement existing WHO guidance on the prevention and treatment of chronic hepatitis C and hepatitis B infection.

Access the new guidelines here.

NAADAC Minority Fellowship Program now accepting applications

NAADAC, the Association for Addiction Professionals, is now accepting applications for its Minority Fellowship Program for Addiction Counselors (NMFP-AC) for the 2017-2018 academic year. Fellows receive a tuition stipend of up to $15,000, as well as training, education, professional development, and mentorship from professionals in the addiction field. Eligible applicants are those who are enrolled in an addiction counseling master’s degree program or a master’s degree program in counseling with an addiction track, and who meet several other criteria. NMFP-AC aims to increase the number of culturally-competent master’s level addiction counselors available to serve underserved and minority populations, as well as transition-aged youth.

Learn more about the Minority Fellowship Program here.

Upcoming Events

Webinar on Complex Trauma, Children, and the Health Home Option: Moving Research and Practice to Policy

This National Child Traumatic Stress Network (NCTSN) is hosting a webinar on Complex Trauma, Children, and the Health Home Option: Moving Research and Practice to Policy. The webinar will describe how NCTSN researchers and practitioners worked with the Center for Medicare and Medicaid Services (CMS), the Substance Abuse and Mental Health Services Administration (SAMHSA), and the New York State Department of Health to establish complex trauma in children as an eligible condition for health home coverage. The webinar will feature several State and federal speakers, including Dr. Larke Nahme Huang, Director of Behavioral Health Equity, and Lead for the Trauma and Justice Strategic Initiative at SAMHSA.

The webinar will be held on Friday, March 10th from 12:00pm-1:30pm EST.

Register for the webinar here. First time NCTSN Learning Center webinar participants will need to set up a free account before registering for the webinar.

Stakeholder Spotlight

The D.C. Update from the National Association of State Alcohol and Drug Abuse Directors (NASADAD) is now featuring a “Stakeholder Spotlight” to highlight the work of a stakeholder group with which NASADAD works closely. The Spotlight will include background on an organization that impacts the substance use disorder field and describe NASADAD’s collaborative efforts with them. This week we’re catching up with the Trust for America’s Health (TFAH).

Catching Up with the Trust for America’s Health (TFAH)

Trust for America’s Health (TFAH) is a nonprofit organization dedicated to “saving lives by protecting the health of every community and working to make disease prevention a national priority.” TFAH has three overarching priorities: 1) Achieve optimal federal support for public health; 2) Advance a modernized public health system; and 3) Highlight key health issues to help advance and improve the public’s health and the public health system. While TFAH addresses a broad range of health issues, in recent years the organization has focused on opioid addiction as a public health crisis. In its Blueprint for a Healthier America 2016: Policy Priorities for the Next Administration and Congress, TFAH emphasized the impact of substance use disorders on communities, highlighting the returns on investment of effective substance use prevention strategies.

NASADAD works with TFAH staff to align legislative priorities as well as funding priorities related to substance use disorder service delivery, especially for programs within the Substance Abuse and Mental Health Services Administration (SAMHSA). In particular, NASADAD collaborates with TFAH as part of the Collaborative for Effective Prescription Opioid Policies (CEPOP), a coalition of stakeholders interested in the appropriate use of opioid medications. We are appreciative of TFAH’s commitment to addressing the opioid crisis, and we are especially grateful for the contributions of Becky Salay, Director of Government Relations, Dalen Harris, the new Director of External Relations and Outreach, and leadership of John Auerbach, President and CEO, and Richard Hamburg, Executive Vice President and COO.

Learn more about TFAH here.

Read TFAH’s Blueprint for a Healthier America 2016 here.

 

Should you have any questions, or require additional information, please do not hesitate to contact Robert Morrison, Executive Director, or Shalini Wickramatilake-Templeman, Federal Affairs Manager, at (202) 293-0090.

Public View

D.C. Update – February 22, 2017

Image

 

Capitol Hill Happenings

News from the States

In the News

Upcoming Events

 

Capitol Hill Happenings

Senate Finance Committee holds confirmation hearing for Seema Verma, appointee for CMS administrator

Last week the Senate Finance Committee held a confirmation hearing for Seema Verma, President Donald Trump’s nominee to serve as administrator of the Centers for Medicare & Medicaid Services (CMS). During the hearing, Ms. Verma, who is a health policy consultant, expressed support for helping rural and other health care providers avoid unnecessary burdens from federal regulatory requirements, including those related to the use of electronic health records. She voiced support for reauthorizing the Children’s Health Insurance Program (CHIP). Additionally, during the hearing Ms. Verma said that she would consider the idea of block granting Medicaid or enacting per-capita caps. Ms. Verma is best-known for her role in developing Healthy Indiana Plan 2.0, the Medicaid expansion plan under former Governor Mike Pence.

Watch the entire confirmation hearing here.

News from the States

Ohio Joint Study Committee on Drug Use Prevention Education releases recommendations on substance abuse education in schools

The Ohio State General Assembly has released the Ohio Joint Study Committee on Drug Use Prevention Education’s report of recommendations on options for implementing age-appropriate substance abuse education in schools across all grade levels. In August 2016, Ohio Attorney General Mike DeWine, former Senate President Keith Faber, and Speaker of the House Clifford Rosenberger formed the Ohio Joint Study Committee on Drug Use Prevention Education. The Committee examined education measures that schools and communities can take to reduce and help prevent substance use disorders. After conducting meetings and research, the Study Committee issued 15 recommendations that are outlined in the new report. The Committee concludes that Ohio schools should provide consistent, age-appropriate, evidence-based substance use disorder education for all students from kindergarten through 12th grade.

Access the full report here.

In the News

Kaiser Family Foundation releases new interactive tool to compare key elements of ACA repeal and replace proposals

The Kaiser Family Foundation (KFF) has released a new interactive tool that allows users to compare key elements of proposals to replace the Affordable Care Act (ACA). The tool enables users to create side-by-side comparisons of major ACA alternative plans, including recent proposals from Sen. Rand Paul (R-KY) and from Sen. Bill Cassidy (R-LA). With the tool, users can compare the plans’ approaches to various key areas of health policy, including individual insurance market rules, requirements and provisions for employers, benefit design, Medicaid, and Medicare.

Access the tool here.

Read Sen. Paul’s legislative proposal here, and Sen. Cassidy’s proposal here.

Humana to stop selling Obamacare health insurance plans next year

Humana, Inc. has announced that it will stop selling Obamacare health insurance plans next year. The company noted that the primary reason behind its decision is the losses caused by consumers who are sicker than Humana had expected. Humana said they expect to lose an estimated $45 million on the policies offered on the exchanges in 11 States this year.  According to an article on the topic featured in Governing magazine, “Humana’s move will probably mean that some 150,000 policy holders in 11 states where Humana sells Obamacare plans will have to switch carriers in 2018; some may be left without any alternative.” While most individuals in the U.S. won’t be significantly impacted by Humana’s decision, some counties may be left with no insurer.

Read the full Governing article here.

Article on State lawmakers who have been personally impacted by opioid crisis

An article recently published by the Associated Press highlights the impact of the opioid crisis on State legislators. The article notes that these lawmakers—who have a family member who has struggled with prescription opioid or heroin addiction, or died from an overdose—are leading legislative efforts to address opioid prevention, treatment, and overdose reversal. For example, “a Pennsylvania lawmaker whose son is a recovering heroin addict championed a State law that expanded availability of an antidote that can reverse an overdose.” The article lists several governors who have been personally impacted by addiction as well.

Read the article here.

New study finds that costs associated with alcoholic liver disease are higher than other alcohol-related conditions

A recent study published in Addiction found that hospital costs for patients with alcoholic liver disease were on average $3,200 higher than for patients admitted for alcohol-related conditions that did not involve the liver. The paper, titled “Identifying Inpatient Costs Attributable to the Clinical Sequelae and Comorbidities of Alcoholic Liver Disease in a National Hospital Database,” found that alcoholic liver disease hospital stays averaged $13,543 compared with $10,355 for other alcohol-related disorders. Researchers used data from the Agency for Healthcare Research and Quality’s (AHRQ) Healthcare Cost and Utilization Project to examine more than 350,000 hospital stays throughout the United States.

Access the article here.

Upcoming Events

SAMHSA webinar on the impact of significant others on women’s recovery

The Substance Abuse and Mental Health Services Administration (SAMHSA) is hosting a webinar on the impact that significant others have on women’s recovery substance use and mental health issues. The webinar will explore the impact of addiction and mental health disorders on significant relationships; interventions that support positive outcomes for women, their partners, and their families; and considerations in service planning. The webinar will be held on Thursday, March 9th from 2:00 – 3:30pm EST.

Register for the webinar here.

Should you have any questions, or require additional information, please do not hesitate to contact Robert Morrison, Executive Director, or Shalini Wickramatilake-Templeman, Federal Affairs Manager, at (202) 293-0090.

News, Public View

New peer-reviewed article highlights State alcohol and drug agencies’ efforts to address opioid crisis

Image

A study recently released in Public Health Reports—the official journal of the U.S. Surgeon General—used data from NASADAD’s 2015 inquiry on States’ efforts to address prescription drug misuse and heroin use to describe how States are combatting the opioid epidemic. The article, titled How States Are Tackling the Opioid Crisis, is the first of its kind to quantify and summarize State-level efforts to combat prescription drug and opioid addiction at detox ohio centers. As federal initiatives by Department of Health and Human Services (HHS) and the Office of National Drug Control Policy (ONDCP) aim to improve substance use disorder prevention and treatment, this article outlines the critical role that States—in particular the State alcohol and drug agencies—have in addressing the opioid crisis. The initiatives undertaken by States that are highlighted in the article include:

  • Educating the general public, prescribers, patients and families, and pharmacists about the risks of opioids;
  • Increasing funding for medication-assisted treatment;
  • Expanding the availability of naloxone;
  • Establishing guidelines for safe opioid prescribing;
  • Requiring prescriber use of prescription monitoring programs;
  • Enacting Good Samaritan laws to protect those helping treat overdoses; and
  • Enacting legislation to regulate pain clinics.

 

Authors offer a review of the literature, noting that State alcohol and drug agencies’ efforts to address opioid misuse and addiction align with intervention models that have been previously evaluated. The article recognizes that State alcohol and drug agencies have demonstrated a robust response to the opioid crisis, and concludes that future efforts should “focus on maintenance and further expansion of the high-quality, evidence-based practices, policies, and programs” that States are already implementing.

Effects of intravenous opioids on eye movements in humans: possible mechanisms

 

Oculomotor symptoms such as downbeat nystagmus can be due to side effects of drugs. We investigated the clinical effects as well as the eye movement symptoms after intravenous administration of opiates (pethidine and fentanyl). Eye movements were recorded with the magnetic search coil technique. All four normal subjects showed a transient disturbance of eye fixation with downbeat nystagmus, a range of saccadic intrusions and oscillations, including square wave jerks and saccadic pulses, lasting from 10 to 15 minutes. The gain of sinusoidal VOR and smooth pursuit was moderately decreased; in particular the vertical pursuit showed an upward velocity offset. On the basis of the clinical findings and of recent diprenorphine PET findings in humans, which detected opiod binding sites in the cerebellum and the known inhibitory action of opiates, we hypothesized that a cerebellar dysfunction occurs after opiate administration which could possibly be mediated by inhibition of the parallel fiber activation of the Purkinje cells. Furthermore, opiate binding sites in the vestibular nuclei could be responsible for the vertical vestibular tonus imbalance involved in the pathophysiolgy of downbeat nystagmus. More information

 

Eye Changes Related to Specific Drugs

Nearly every substance of abuse can cause changes in the eyes. Below are specific changes in pupils, eye motion, or vision that can indicate intoxication or overdose from specific substances.

  • Alcohol: Intoxication can cause double vision or blurry vision.
  • Amphetamines: Ecstasy, Molly, MDMA, and similar drugs can cause blurred vision and changes in pupil size. The drugs can also cause rapid quivering of the pupils (nystagmus).
  • Benzodiazepines: Like alcohol, at recreational doses, these medications can cause altered, double or blurry vision. Dilated pupils are a sign of an overdose.
  • Cigarettes: Smoking in general, and smoking cigarettes in particular, can lead to cataracts of the crystalline lens – an area of the eye that produces one-third of the image the brain processes by focusing light onto the retina. That is why they recommend to use vaporizers, which work with vapor and not smoke, it helps the body and distracts the mind, you use them with different types of liquids, in Liquido24 you can find many flavors, with or without nicotine.
  • Cocaine and crack cocaine: As the drug stimulates the brain and releases endorphins and adrenaline, the body will react by dilating the pupils. Symptoms of overdose include hallucinations, including visual hallucinations.
  • Dextromethorphan: A common cough-suppressing ingredient in cold and flu medicines, this substance can cause intoxication. A symptom of DXM abuse is rapid, involuntary eye movements called nystagmus.
  • GHB: A depressant sometimes called liquid ecstasy, GHB can be abused by putting the drug in eyes using eye drops. It is, however, more commonly mixed into a drink and consumed orally. The drug also causes hallucinations.
  • Hallucinogens: Mescaline, LSD, and other, similar drugs cause the pupils to dilate. The user experiences hallucinations, which may be visual.
  • Heroin: This narcotic can cause drooping eyelids due to sleepiness. The drug will also cause the pupils to constrict, leading to pinpoint pupils.
  • Inhalants: Abusing substances like paint thinner or nitrous in canisters can lead to watering and red eyes as a sign of intoxication.

 

Read the full article here.

Public View

D.C. Update– February 15, 2017

Image

 

News from NASADAD

Around the Agencies

Capitol Hill Happenings

News from the States

In the News

Upcoming Events

 

News from NASADAD

New peer-reviewed article highlights SSA efforts to address opioid crisis

A study recently released in Public Health Reports—the official journal of the U.S. Surgeon General—used data from NASADAD’s 2015 inquiry on States’ efforts to address prescription drug misuse and heroin use to describe how States are combatting the opioid epidemic. The article, titled How States Are Tackling the Opioid Crisis, is the first of its kind to quantify and summarize State-level efforts to combat prescription drug and opioid addiction. As federal initiatives by Department of Health and Human Services (HHS) and the Office of National Drug Control Policy (ONDCP) aim to improve substance use disorder prevention and treatment, this article outlines the critical role that States—in particular the State alcohol and drug authorities—have in addressing the opioid crisis. The initiatives undertaken by SSAs that are highlighted in the article include:

  • Educating the general public, prescribers, patients and families, and pharmacists about the risks of opioids;
  • Increasing funding for medication-assisted treatment;
  • Expanding the availability of naloxone;
  • Establishing guidelines for safe opioid prescribing;
  • Requiring prescriber use of prescription monitoring programs;
  • Enacting Good Samaritan laws to protect those helping treat overdoses; and
  • Enacting legislation to regulate pain clinics.

 

Authors offer a review of the literature, noting that SSAs’ efforts to address opioid misuse and addiction align with intervention models that have been previously evaluated. The article recognizes that State alcohol and drug authorities have demonstrated a robust response to the opioid crisis, and concludes that future efforts should “focus on maintenance and further expansion of the high-quality, evidence-based practices, policies, and programs” that States are already implementing.

The paper has already been downloaded 630 times, and last week the Surgeon General, Dr. Vivek Murthy, Tweeted about the article.

NASADAD staff are appreciative of the SSAs for taking the time to complete the 2015 prescription drug and heroin inquiry, as it culminated in this publication.

Read the full article here.

NASADAD releases updated fact sheet on opioids

NASADAD has released an updated fact sheet on opioids. The fact sheet provides an overview of opioid pain relievers and heroin. It reviews evidence-based, cost-effective treatment options for opioid addiction, as well as the overdose reversal drug, naloxone. The fact sheet also highlights key federal agencies in the effort to prevent and treat opioid addiction, such as the Substance Abuse and Mental Health Services Administration (SAMHSA), and federal programs, such as the State Targeted Response to the Opioid Crisis Grants.

Access the fact sheet here.

Around the Agencies

GAO report highlights impact of data limitations on Medicaid

The Government Accountability Office (GAO) has released a report on data limitations that impact the Centers for Medicare & Medicaid Services (CMS). The report—titled Program Oversight Hampered by Data Challenges, Underscoring Need for Continued Improvements—notes that Medicaid uses State-reported data that may be inaccurate or incomplete. The GAO recommends that CMS take immediate steps to improve Medicaid data available for program oversight.

Read the full report here.

CDC releases article on e-cigarettes and young people

The Office on Smoking and Health (OSH) within the Centers for Disease Control and Prevention (CDC) has released an article to complement the Surgeon General’s recently published report, E-cigarette Use Among Youth and Young Adults. The article, titled E-cigarettes and Young People: A Public Health Concern, contains an overview of e-cigarettes; a call to action for parents to talk to their children about the risks associated with e-cigarette use; a list of specific actions that parents and other adults can take to address e-cigarette use among young people; and other resources.

The Surgeon General’s report on e-cigarettes can be accessed here.

Read the full OSH article here.

NIDA features guest blog by former Legal Action Center (LAC) colleague on access to substance use disorder treatment in Baltimore

The National Institute on Drug Abuse (NIDA) has published a guest blog post on its website on Improving Access to Substance Use Disorder Treatment in Baltimore City. The blog was authored by Mark L. O’Brien, Director of Opioid Overdose Prevention and Treatment at the Baltimore City Health Department, and Dr. Leana S. Wen, the Baltimore City Health Commissioner. Mark O’Brien previously worked at the Legal Action Center (LAC) where he led efforts on criminal justice reform. NIDA has been working with the Baltimore City Health Department to address the opioid crisis in Baltimore by improving access to treatment for individuals with an opioid use disorder. The blog post highlights the programs and policies that have been implemented in Baltimore, such as a 24/7 hotline for addiction services, a 24/7 stabilization center, and increasing access to medication-assisted treatment.

Read the full blog post here.

HHS releases summary report of Expert Consultation on the Evidence for Early Hepatitis C (HCV) Treatment

The Department of Health and Human Services (HHS) has released a report as follow-up from the September 2016 Expert Consultation on the Evidence for Early Hepatitis C (HCV) Treatment in the United States. The HHS-convened Expert Consultation meeting aimed to identify barriers to accessing hepatitis C treatment and potential strategies for ensuring that people who are infected can get the treatment they need. The report summarizes the Expert Consultation meeting, and categorizes key issues related to HCV treatment in the following areas: payer restrictions, improving HCV surveillance and health care data, HCV treatment outcomes, health care system capacity, and HCV screening.

Read the full report here.

Capitol Hill Happenings

House Bipartisan Heroin Task Force hosts roundtable on heroin and synthetic drugs

Last week the House of Representatives Bipartisan Heroin Task Force hosted a roundtable on heroin and synthetic drug abuse. Co-chairs of the Task Force, Tom MacArthur (R-NJ) and Ann Kuster (D-NH), made opening remarks. Featured speakers included: Nora Volkow, Director of the National Institute of Drug Abuse (NIDA); Corey Waller, Advocacy Committee Chairman of the American Society of Addiction Medicine (ASAM);  Josh Rising, Director of Health Programs for the Pew Charitable Trusts; and Lisa Marsch, Director of the Dartmouth Center for Technology and Behavioral Health. The topics covered during the roundtable included how heroin and synthetic drugs affect the brain; the importance of communication between doctors and families on treatment plans for individuals with an addiction; the need for alternative pain medicine; and the potency of synthetic drugs.

Watch a recording of the roundtable here.

News from the States

Philadelphia Department of Behavioral Health and disAbility Services releases an Peer Support Toolkit

The Philadelphia Department of Behavioral Health and disAbility Services has released an interactive Peer Support Toolkit. The toolkit offers provides compendium of practices and tools that aims to help increase the effectiveness of peer support services. The toolkit is organized in four modules that address different stages of implementing peer support services: 1) Preparing the Organizational Culture; 2) Recruiting and Hiring Peer Staff; 3) Service Delivery; and 4) Supervision and Retention. The toolkit was developed with support from the Great Lakes Addiction Technology Transfer Center (Great Lakes ATTC).

Download the toolkit here.

In the News

National Academy for State Health Policy releases report on Health Savings Accounts

The National Academy for State Health Policy (NASHP) has released a report titled, Health Savings Accounts —Lessons from States; Questions for Policymakers. The report provides an overview of Health Savings Accounts (HSAs) and describes the impact of HSAs with high-deductible health plans (HDHPs) on low-income individuals. Additionally, the report highlights Indiana and Michigan as States that have been granted Section 1115 waivers and have incorporated HSAs or similar accounts into their Medicaid expansions.

Access the full report here.

Upcoming Events

SAMHSA-HRSA Center for Integrated Health Solutions webinar on Addressing Behavioral Health with Older Adults in Primary Care

The Substance Abuse and Mental Health Services Administration (SAMHSA)- Health Resources and Service Administration (HRSA) Center for Integrated Health Solutions will be holding a webinar tomorrow on mental health and substance use disorder services for older adults. The webinar is titled Aging Well: Addressing Behavioral Health with Older Adults in Primary Care Settings. Guest presenters include: Dr. Dr. Steven Bartels, Director of the Dartmouth Centers for Health and Aging, Amanda Pettit, Clinic Nurse Manager at Crossing Rivers Health, and Ashley Hady, Licensed Clinical Social Worker at Crossing Rivers Health. The webinar will be held on Wednesday, February 15that 1:00pm EST.

Register for the webinar here.

Should you have any questions, or require additional information, please do not hesitate to contact Robert Morrison, Executive Director, or Shalini Wickramatilake-Templeman, Federal Affairs Manager, at (202) 293-0090.